Five Oceans Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
7,396
+489
+7% +$21K 0.11% 119
2026
Q1
$254K Buy
6,907
+1,260
+22% +$59.7K 0.09% 145
2025
Q4
$287K Sell
5,647
-3,213
-36% -$164K 0.1% 126
2025
Q3
$492K Sell
8,860
-6,902
-44% -$404K 0.18% 64
2025
Q2
$1.09M Sell
15,762
-4,263
-21% -$290K 0.46% 31
2025
Q1
$1.39M Hold
20,025
0.67% 24
2024
Q4
$1.72M Hold
20,025
0.79% 27
2024
Q3
$2.38M Hold
20,025
1.14% 19
2024
Q2
$2.86M Sell
20,025
-2,417
-11% -$320K 1.5% 15
2024
Q1
$2.88M Hold
22,442
1.48% 15
2023
Q4
$2.32M Sell
22,442
-3,544
-14% -$350K 1.3% 14
2023
Q3
$2.36M Hold
25,986
1.52% 13
2023
Q2
$2.1M Sell
25,986
-7,952
-23% -$650K 1.35% 13
2023
Q1
$2.7M Hold
33,938
1.75% 12
2022
Q4
$2.3M Hold
33,938
1.59% 12
2022
Q3
$1.69M Buy
33,938
+7,840
+30% +$420K 1.34% 13
2022
Q2
$1.45M Buy
26,098
+1,638
+7% +$90.9K 1.08% 19
2022
Q1
$1.36M Buy
24,460
+5,966
+32% +$306K 1.21% 19
2021
Q4
$1.04M Buy
18,494
+6,614
+56% +$358K 0.91% 24
2021
Q3
$570K Buy
+11,880
New +$574K 0.66% 35

Other funds holding NVO

Five Oceans Advisors's NVO Position: Q2 2026 in Review

Five Oceans Advisors increased its Novo Nordisk (NVO) stake by 7.1% in Q2 2026, buying an estimated $21K and bringing the position to 7,396 shares worth $355K. The position accounts for 0.11% of the portfolio, ranked #119.

Five Oceans Advisors first reported a position in NVO in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.88M in Q1 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Five Oceans Advisors held 7,396 shares of Novo Nordisk worth $355K as of Q2 2026.
  • Five Oceans Advisors bought 489 Novo Nordisk shares in Q2 2026, an estimated $21K.
  • Novo Nordisk made up 0.11% of Five Oceans Advisors's portfolio in Q2 2026, its #119 holding.
  • Five Oceans Advisors first reported a position in Novo Nordisk in Q3 2021 and has held it in 20 quarters since.
  • Five Oceans Advisors's Novo Nordisk position peaked at $2.88M in Q1 2024.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.